Market Size (2018)
2018
$1.39B
Healthcare
PEG 3350 Market
By Segment, By Region, And Segment Forecasts, 2018 – 2030
Vertical: HealthcareBase Year: 202112 Sections
Executive Summary
PEG 3350 Market — Snapshot
Projected (2030)
2030
$2.73B
CAGR (2018–2030)
5.8%
5.8%Key Players
108+
The global PEG 3350 market is growing as a result of factors such as the rising prevalence of colon cancer in India, the rising number of strategic initiatives, and increasing sedentary lifestyles and physical inactivity. Furthermore, entering developing markets further creates lucrative growth opportunities. However, side effects associated with PEG 3500 and an increasing preference for alternatives are impeding the market's growth.
Key Insight
The PEG 3350 Market market is projected to grow at a CAGR of 5.8% from 2018 to 2030.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: North America, Europe, Asia Pacific, Rest of the World.
- Market Segmentation: The market is analyzed across 2 segments: Powder, Bowel Preparation Kit. Forecasts are provided for each segment from 2018 to 2030.
- Competitive Landscape: 108 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
PEG 3350 Market — Growth Trajectory
Polyethylene glycol 3350 is in a class of medications called osmotic laxatives. Its main role is to cause water to be retained in the stool. This increases the number of bowel movements and softens the stool, making it easier to pass. It is commonly used to treat constipation, before medical tests of the colon and rectum, before colorectal surgery, and after surgery to alleviate constipation.
PEG 3350 Market — Growth Trajectory
Powder
Bowel Preparation Kit
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- By Product Type By Product Type is broken down into: Powder, Bowel Preparation Kit.
- By Age By Age is broken down into: Pediatric, Adult, Geriatric.
- By Application By Application is broken down into: Constipation, Medical Tests, Surgery.
- By Distribution Channel By Distribution Channel is broken down into: Online Pharmacy, Offline Pharmacy.
Geographic Analysis
Regional market breakdown
- North America North America market size reached $566.24M in 2018 and is projected to reach $1.15B by 2030, growing at a CAGR of 6.1%.
- Europe Europe market size reached $377.55M in 2018 and is projected to reach $706.19M by 2030, growing at a CAGR of 5.4%.
- Asia Pacific Asia Pacific market size reached $243.52M in 2018 and is projected to reach $583.30M by 2030, growing at a CAGR of 7.6%.
- Rest of the World Rest of the World market size reached $205.71M in 2018 and is projected to reach $293.56M by 2030, growing at a CAGR of 3.0%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
PEG 3350 Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2021
Historical Period
2018 – 2021
Forecast Period
2021 – 2030
Primary Interviews
150+
Research Process
Historical data (2018–2021) and forecast period (2021–2030)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
PEG 3350 Market — Competitive Analysis
Threat of New Entrants
The threat of new entrants in the global PEG 3350 market is moderate. The global PEG 3350 market is steadily growing, hence attracting many new entrants who are looking to make a profit. However, the entry barriers are high due to strict government norms and regulations which decreases the threat of new entrants to some level. Companies aim to increase their market share and capture the market share which is mostly untouched by major players. Hence, the threat of new entrants in the global PEG 3350 market is moderate.
Bargaining Power of Suppliers
The bargaining power of suppliers in the global PEG 3350 market is high as there is an increase in demand for raw materials by pharmaceutical companies. However, the number of suppliers is also high in the market, which is slightly decreasing the bargaining power of suppliers, as switching cost is low. Additionally, the supply of raw materials is disrupted to some level due to the logistics issues that the world is facing currently, which in turn increases the bargaining power of suppliers.
Threat of Substitutes
The threat of substitutes in the PEG 3350 market is high. There are many substitutes for PEG 3350 such as magnesium citrate supplement and presence of natural alternatives. The doctors tend to prescribe the type of treatment that is suitable for the patient and also affordable.
Bargaining Power of Buyers
The bargaining power of buyers is moderate in the global PEG 3350 market. Online pharmacies and offline pharmacies are the major buyers in the market. The bargaining power of the buyer can define how easily the buyer can get the products. Buyers in the global PEG 3350 market can choose from different companies. Most of the companies are offering the same kind of products so the switching cost for the buyer is relatively low.
Intensity of Rivalry
The degree of competition in the PEG 3350 market is high owing to the presence of a large number of prominent players. Low level of product differentiation among existing players increases the intensity of rivalry in the market. Polyethylene glycol 3350 companies are trying to develop economical and more effective medications to make the treatment more affordable and attractive. Additionally, the providers are also involved in innovating medicines for the different routes of administration. Such innovations might increase the level of product differentiation and will support the sales of the manufacturers.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for PEG 3350 Market.
Regional Market Size (USD Mn)
Market estimates by geography (2030)
USD Mn
InsightNorth America leads with $1.15B by 2030, while Asia Pacific is projected to grow fastest at a 7.6% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2018 | 2021 | 2030 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $566.24M | $770.97M | $1.15B | 6.1% | 42% |
| Europe | $377.55M | $493.86M | $706.19M | 5.4% | 26% |
| Asia Pacific | $243.52M | $361.85M | $583.30M | 7.6% | 21% |
| Rest of the World | $205.71M | $238.35M | $293.56M | 3.0% | 11% |
| Total | $1.39B | $1.87B | $2.73B | 5.8% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSegment Revenue (2030)
Powder
Bowel Preparation Kit
043687213081744
Segment Market Share
- Powder58%
- Bowel Preparation Kit42%
Total Market Size
$2.73B
Market by Segment (2030)
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Powder | $1.59B | 5.8% | 53% |
| Bowel Preparation Kit | $1.15B | 5.8% | 81% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
PEG 3350 Market — Key Findings
Analytical insights on PEG 3350 Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The PEG 3350 Market market is projected to reach $2.73B by 2030, growing at 5.8% CAGR. The Powder segment holds the largest share.
Market Dynamics
The rising prevalence of colon cancer in India and other developing nations is one of the major factors driving the growth of the global PEG 3350 market. Likewise, the rising number of strategic initiatives is further fueling the growth of the global market during the review period. However, side effects associated with PEG 3500 are anticipated to hamper the growth of the global market. Nevertheless, market expansion in developing regions is expected to create lucrative opportunities for the players operating in the global PEG 3350 market.
Market Drivers
The prevalence of colon cancer is increasing across India and other developing nations. In countries such as India, China, and Japan cases of colon cancer is increasing at a high rate. For instance, according to the article published by, lancet regional health Southeast Asia, colorectal cancer is the 7th most common cancer in India with 65,358 new cases in 2021. The incidence of colon cancer has been increasing worldwide and is currently 19.5 per 100,000 population globally and 15.2 per 100,000 population in India. Similarly, the changing lifestyles that include consumption of calorie-rich and low fibre diet, excessive use of red meat and processed foods, and physical inactivity. Also, the age-sex-adjusted rates of colon cancer in India have also raised by 20.6%, with a sharp increase in adults aged under 50 years.
Therefore, the rising number of colon cancers is likely to increase the demand for PEG 3350. This cumulative prevalence of colon cancer along with changing lifestyle habits such as rising consumption of alcohol and tobacco products, increasing rates of smoking, and poor dietary habits among the population are expected to drive the PEG 3350 markets during the forecast period.
Market Opportunities
Developing economies pose an opportunity for the PEG 3350 market as they have a developing R&D sector along with improving healthcare infrastructure, owing to which they are capable of addressing upcoming health challenges. In spite of huge demand, several countries are dependent on imported medicines and other health technologies. Although there is a high disease prevalence rate and requirement for treatment, poor economic conditions lead to the slow growth of the healthcare industry within the developing region.
According to the report published by the Colorectal Cancer in the Arab World, there will be 1.93 million new cases of colon cancer present in Arab counties. Cancer is growing at an alarming pace in Middle East region countries. Similarly, 6,597 cases were registered in Malaysia in 2021. The increasing patient pool offers growth opportunities for manufacturers in the PEG 3350 market to expand their reach in such nations and aid in the growth of the global PEG 3350 market.
Market Restraints
Strict PEG 3350 is a group of medications called osmotic laxatives. It usually works by allowing water to be more easily absorbed into the stool. This helps stool pass more easily. Polyethylene glycol 3350 works well and doesn’t usually have serious risks. But side effects of constipation treatments vary depending on the method person chooses and the strength of the medication. The most common side effects include nausea, gas, and bloating. These side effects usually are managed at home. The side effects of oral medications can be more serious. It can even upset the stomach or make patients dizzy and lightheaded. Moreover, oral medication can also cause severe side effects, especially severe diarrhoea. The medication can also increase the irritation of the rectum, sleep disorder, and intense abdominal pain. The safety issues regarding constipation-treated products are expected to hamper the market growth.
Strategic Outlook and Future Directions
The COVID-19 pandemic has caused major destruction in the delivery of healthcare products across the world. It has posed limitations on many patients to access their standard health services such as visits to healthcare professionals, diagnosis, and medications. It has adversely impacted the ability of patients and practitioners to adhere to treatment guidelines. Moreover, the high demand for PEG 3350 and growing awareness about current and new products is also fueling the global PEG 3350 market. For instance, as per the All-India Trade Survey of Prioritised Medicinal Plants, 2019, demand for medicinal plants such as Senna Makki increased by 50%, while the availability declined by 26% during COVID-19. Similarly, the US FDA has also allowed Senna Makki to be used as an over-the-counter drug in case of digestive disorders, such as chronic constipation, hemorrhoids, and irritable bowel syndrome, as it causes laxative action by influencing the transport of water and electrolytes. Hence, the COVID-19 pandemic had a negative impact on the market demand during the initial phase, however, demand normalized as supply chain issues were resolved and restrictions were lifted to some extent.
COVID-19 has led to a disruption in the supply chain of PEG 3350 products. Lockdown policies in different countries have resulted in the closing of product providers and decreasing walk-in customers to prevent the spread of the disease. This led to a significant delay in the supply of the product. Also, during the lockdown period, the PEG 3350 market for online delivery of products has seen a rise, which nullified the negative impact on physical pharmacies to some extent. The leading companies of the PEG 3350 market across the world have taken major steps to properly supply their products to people globally.
The COVID-19 pandemic situation has resulted in many restrictions around the world, still, the players manufacturing PEG 3350 products were able to manage their product stock. Further, governing bodies of respective nations made significant efforts to aid in the proper distribution and supple of healthcare goods. Government and private companies around the world were working together to issue advice for those undergoing constipation treatment during these unprecedented times of COVID-19 around the world. Several steps were taken to get their needed output for the product. Additionally, by increasing the material prices, the companies attempted in maintaining their overall revenue. Hence, companies in the PEG 3350 market are finding out their ways to deal with this pandemic situation.
Market Value by Segment (2030)
Value (USD Mn)
Powder
Bowel Preparation Kit
Companies
Key companies profiled in PEG 3350 Market
Profiles of 108 companies operating in the PEG 3350 Market market, including revenue, employee count, and market positioning where available.
Showing 108 of 108 companies
Pendopharm
Pendopharm
Healthcare
Company Headquarters: Quebec, Canada Founded: 2003 Workforce: ~ 1,500 Company Working: Pendopharm manufactures and distributes pharmaceutical products. The Company offers licensing, partnering, developing, and marketing specialty prescription medicines, as well as consumer healthcare products. Pendopharm serves customers in Canada. Moreover, it also offers more than 40 specialty products across multiple therapeutic areas. Pendopharm operates as a subsidiary of Pharmascience Inc. In addition, the company established lasting and fruitful relationships with Canadian healthcare professionals through the development of partnerships and sustained delivery of quality products and value-added service.
RevenueN/A
Employees1,500
Market CapN/A
Founded2002
Quebec, Canada
Sisco Rese
Sisco Research Laboratories Pvt.
Healthcare
Company Headquarters: Mumbai, India Founded: 1975 Workforce: ~ 200-500 Company Working: Sisco Research Laboratories Pvt. Ltd. (SRL), one of India's oldest and most reputable manufacturers and suppliers, manufactures and provides almost 5000 high-quality Laboratory Chemicals and Related Products. The business specialises in culture media, high purity solvents, BioLitTM DNA & Protein Tools for PCR and conventional molecular biology, as well as Molecular Biology Reagents, Biochemicals, Enzymes, Nanopowders, and Carbon Nanotubes. SRL was founded in 1975, and for more than 40 years the company has been producing highly sophisticated, high-quality biochemicals and reagents in India. Around 5000 goods in various grades, product sectors, and conventional packing sizes are produced and marketed by the company. The company also provides these high-tech chemicals in bulk and semi-bulk packs for the broader requirements of R&D and production units of various companies, universities, and research institutes.
RevenueN/A
Employees500
Market CapN/A
Founded1974
Mumbai, India
LGM Pharma
LGM Pharma
Healthcare
Company Headquarters: Florida, US Founded: 2005 Workforce: ~100 Company Working: LGM Pharma is one of the active pharmaceutical ingredient companies that offers API sourcing as well as drug product contract development and manufacturing solutions to the biotechnology, pharmaceutical, and compounding pharmacy industries. It has ISO 9001:2015 certification. The company has an unparalleled network of prequalified cGMP API manufacturers around the globe. It has US-based manufacturing and warehouse facilities and has delivered more than 6,000 APIs to its clients in the last three years.
RevenueN/A
Employees100
Market CapN/A
Founded2004
Florida, US
McKesson C
McKesson Corporation
Healthcare
Company Headquarters: Irving, Texas, US Founded: 1830 Workforce: Company Working: McKesson Corporation is a healthcare information technology and medical distribution company. The company provides medical supplies, prescription and over the counter (OTC) drugs, healthcare IT, and pharmacy management software. It operates its business through two reportable segments, namely, McKesson Distribution Solutions (MDS) and McKesson Technology Solutions (MTS). Its distribution solutions segment distributes specialty, generic, brand, over the counter (OTC) and biosimilar pharmaceutical drugs, and other healthcare related products throughout the globe. Its technology solutions segment offers supply chain and financial and clinical management solutions to healthcare organizations. It operates majorly in the US, Germany, and Canada. McKesson Corporation and Change Healthcare Holdings, Inc. (CHC), a leading provider of technology-enabled services, network solutions, and software and analytics; formed a new healthcare information technology company named Change Healthcare in 2016.
Revenue$137.4B
Employees2,016
Market CapN/A
Founded1829
Irving, Texas, US
BASF SE
BASF SE
Chemicals & Materials
Company Headquarters: Germany Founded: 1865 Workforce: ~111,047 Company Working: BASF SE (BASF) is a chemical enterprise that engages in the manufacturing, promotion and distribution of various products, such as chemicals, plastics, crop protection and performance products. BASF SE is a German multinational chemical company that operates in six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The company is committed to sustainability and has set ambitious targets to reduce its environmental impact, including reducing greenhouse gas emissions, increasing energy efficiency, and promoting a circular economy. BASF SE offers a wide range of chemical products, including plastics, performance products, functional solutions, and agricultural solutions, among others. The company has a strong global presence with production sites in over 80 countries and a customer base that spans various industries, including automotive, construction, agriculture, and consumer goods. The company's product line encompasses a wide array of offerings, such as solvents, adhesives, dyes, surfactants, fuel additives, electronic chemicals, pigments, paints, food additives, fungicides, and herbicides. BASF serves an extensive range of industries including construction, furniture and wood, agriculture, electronics and electrical, paints and coatings, automotive, home care, nutrition, chemicals, and other related sectors. Additionally, BASF collaborates with global customers, scientists, and partners to carry out research and development initiatives. The company operates through a network of manufacturing facilities located worldwide, with a presence in Europe, Asia Pacific, South America, Africa, the Middle East, and North America. BASF and DIC had reached an agreement on the acquisition of BASF’s global pigments business with about 2,600 employees on August 29, 2019
Revenue$98.8B
Employees111,047
Market CapN/A
Founded1864
Germany
Merck KGaA
Merck KGaA
Healthcare
Company Headquarters: Darmstadt, Germany Founded: 1668 Workforce: ~60,348 Company Working: Merck KGaA (Merck) is a pharmaceutical company that offers a varied range of products subgrouped into three segments—healthcare, life sciences, and performance materials. The company delivers innovative health solutions and is dedicated to providing breakthrough solutions and technologies. The company research drugs in the areas of oncology and neurodegenerative as well as autoimmune and inflammatory diseases. It also markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for industries such as pharmaceuticals, food, cosmetics, packaging, and coatings. It has expanded its global footprint through several mergers and acquisitions, such as the acquisition of Millipore and Sigma-Aldrich. The company is distributing its products in the following countries: China, India, Japan, Australia, Israel, United Arab Emirates, South Korea, Denmark, Italy, Netherlands, Spain, United Kingdom, Switzerland, Sweden, Argentina, Brazil, Canada, US, New Zealand among others.
Revenue$21.5B
Employees60,348
Market CapN/A
Founded1667
Darmstadt, Germany
Page 1 of 18
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
PEG 3350 Market
Starting from
$4,950